AGP Picks
View all

Slovak AI hologram project wins EU REGIOSTARS award

4 hours ago
By AI, Created 17:59 UTC, Oct 16, 2026, AGP -

Košice-based MATSUKO and Pavol Jozef Šafárik University won the European Commission’s REGIOSTARS 2026 award for an AI system that turns a single camera into a live 3D hologram. The win highlights an Eastern Slovak startup reaching Europe-wide recognition while moving into healthcare, telecom and space applications.

Why it matters: - MATSUKO’s win puts a Slovak startup on the top tier of EU cohesion-policy projects. - The award spotlights Eastern Slovakia as a source of advanced AI, not just outsourced tech work. - The hologram system already has uses in healthcare, telecom and training, which broadens its commercial impact.

What happened: - The European Commission named the AI Holopresence project by MATSUKO and Pavol Jozef Šafárik University a REGIOSTARS 2026 winner. - The project won the category “A Competitive and Smart Europe,” which recognizes innovative projects. - The award was presented on Wednesday, 14 October, in Brussels during the closing gala for the European Week of Regions and Cities. - MATSUKO CEO Mária Virčíková and Head of Strategy Matúš Durkáč accepted the award. - This was Slovakia’s first time reaching a finalist spot in this category. - The project beat entries from Cyprus, the Netherlands, Lithuania and Portugal after a record 274 applications from across Europe.

The details: - AI Holopresence creates a photorealistic 3D hologram of a real person in real time from a single ordinary camera. - The system works without special equipment and lets people meet in extended reality as themselves rather than as avatars or flat video tiles. - MATSUKO’s patented model fills in visual data the camera cannot capture on its own. - The company completed core research from 2020 to 2023 with mathematicians from the university’s Faculty of Science. - The research was funded by the European Regional Development Fund through the Operational Programme Integrated Infrastructure. - The Slovak Ministry of Transport and the Ministry of Economy managed that funding. - All three resulting patents have been granted in the United States. - The research has since drawn more than €8 million in additional funding. - The technology has been selected by Orange, T-Mobile, Vodafone and Telefónica. - The EU-backed 6G-XR project used the system as a flagship use case for 6G network development alongside Ericsson, Nokia and Intel in nine countries. - Orange uses the technology in retail customer service, where an AI hologram greets and assists shoppers. - The mobile version is available at matsumi.ai. - More than 500 students in schools across the Košice Region have completed holographic training.

Between the lines: - The award signals that a university-startup partnership from a smaller region can compete with projects from much larger innovation hubs. - The healthcare use case is especially practical because specialist ADHD diagnosis for children is scarce. - The space-testing interest suggests the technology may work in places where physical experts cannot easily travel. - The telecom and retail deployments indicate the project is moving beyond research and into real-world service delivery.

What's next: - MATSUKO plans pilot use in healthcare in the United Kingdom and Luxembourg. - In the ADHD workflow, a child will visit a mobile clinic van and appear as a hologram in an expert’s office for observation. - The European Space Agency has shown interest in testing holographic communication over a satellite link. - MATSUKO will work with the Technical University of Košice, the Košice Self-Governing Region and the City of Košice on a lifelong learning center. - That center will use holograms for training students and seniors.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Healthcare News Netherlands

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Healthcare News Netherlands

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.